Latest News and Press Releases
Want to stay updated on the latest news?
-
LOUISVILLE, CO--(Marketwire - October 25, 2007) - GlobeImmune, Inc. announced today results from research on its GI-10001 Tarmogen® which is being investigated for the treatment of drug...
-
LOUISVILLE, CO--(Marketwire - September 26, 2007) - GlobeImmune, Inc. today announced it has raised $41.2 million through a Series C Preferred Stock financing. This round was led by Wexford Capital...
-
LOUISVILLE, CO -- (MARKET WIRE) -- January 5, 2007 -- GlobeImmune, Inc. announced today that President and Chief Executive Officer Timothy C. Rodell, M.D. will present at the JPMorgan Healthcare...
-
LOUISVILLE, CO -- (MARKET WIRE) -- January 3, 2007 -- GlobeImmune, Inc. announced today that President and Chief Executive Officer, Timothy C. Rodell, M.D., will present at the JPMorgan Healthcare...
-
LOUISVILLE, CO -- (MARKET WIRE) -- October 30, 2006 -- GlobeImmune, Inc. today announced positive interim results from Study GI-5005-01, a randomized, placebo-controlled, multi-center,...
-
LOUISVILLE, CO -- (MARKET WIRE) -- October 17, 2006 -- GlobeImmune, Inc. announced today that the interim results from a placebo-controlled Phase 1b study of GI-5005 in patients chronically infected...